Results 231 to 240 of about 4,177,043 (382)
Objectives Evaluate the efficacy and safety of baricitinib in paediatric patients with active JIA‐U or chronic anterior ANA‐positive uveitis, who had an inadequate response to MTX or bDMARDs. Methods JUVE‐BRIGHT was an open‐label, active‐controlled, Phase‐3 multicentre trial which utilized a novel design, including 1:1 randomization to an active ...
Athimalaipet V. Ramanan +7 more
wiley +1 more source
Design and analysis of a GaN-based 2D photonic crystal biosensor integrated with machine learning techniques for detection of skin diseases. [PDF]
N H, A S.
europepmc +1 more source
Objective Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against nonsteroidal anti‐inflammatory drug (NSAID) use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal
Adam S. Mayer +5 more
wiley +1 more source
Detection and imaging of chemicals and hidden explosives using terahertz time-domain spectroscopy and deep learning. [PDF]
Jiang X +5 more
europepmc +1 more source
All-Optical Label Swapping of Scalable In-Band Address Labels and 160-Gb/s Data Packets
Member Ieee Nicola Calabretta +5 more
semanticscholar +1 more source
Objective Ultrasound (US) has been proposed as a potential tool for assessing skin fibrosis in systemic sclerosis (SSc). However, a large‐scale comparison of US‐based assessment with histologic markers of skin fibrosis has not been reported. We evaluated US‐based skin assessments for their face validity (differentiation between involved SSc and healthy
Ruhani Desai +12 more
wiley +1 more source
Learning Domain-Invariant Representations for Event-Based Motion Segmentation: An Unsupervised Domain Adaptation Approach. [PDF]
Jeryo M, Harati A.
europepmc +1 more source
Optical screening of citrus leaf diseases using label-free spectroscopic tools: A review
Saurav Bharadwaj +4 more
openalex +1 more source
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source

